Skip to main content

ShockWave Medical, Inc. (SWAV)

NASDAQ: SWAV · IEX Real-Time Price · USD
216.84 -10.21 (-4.50%)
Sep 20, 2021 9:31 AM EDT - Market open
Market Cap7.98B
Revenue (ttm)130.11M
Net Income (ttm)-52.83M
Shares Out35.03M
EPS (ttm)-1.53
PE Ration/a
Forward PE131.58
Dividendn/a
Ex-Dividend Daten/a
Volume14,812
Open-
Previous Close227.05
Day's Range216.84 - 219.41
52-Week Range66.09 - 237.76
Beta1.28
AnalystsBuy
Price Target210.67 (-2.8%)
Est. Earnings DateNov 9, 2021

About SWAV

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists ...

IndustryHealth Care Equipment & Supplies
IPO DateMar 7, 2019
CEODouglas Godshall
Employees449
Stock ExchangeNASDAQ
Ticker SymbolSWAV
Full Company Profile

Financial Performance

In 2020, SWAV's revenue was $67.79 million, an increase of 57.92% compared to the previous year's $42.93 million. Losses were -$65.70 million, 28.5% more than in 2019.

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for SWAV stock is "Buy." The 12-month stock price forecast is 210.67, which is a decrease of -2.85% from the latest price.

Price Target
$210.67
(-2.85% downside)
Analyst Consensus: Buy

News

Why Did Shockwave Medical Stock Gain 18% in August?

The medical device stock is growing even quicker than investors anticipated.

1 week ago - The Motley Fool

Shockwave Medical to Participate in Two Upcoming Virtual Investor Conferences

SANTA CLARA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular ...

3 weeks ago - GlobeNewsWire

This Healthcare Stock Grew Revenue by More Than 400% in the Second Quarter

Here's one innovative company you might want to put on your radar.

3 weeks ago - The Motley Fool

ShockWave Medical (SWAV) Q2 Earnings, Revenues Top Estimates

ShockWave Medical's (SWAV) robust performance across product lines and geographies drive its Q2 sales.

1 month ago - Zacks Investment Research

Why Shockwave Medical Surged as High as 10% Today

Top- and bottom-line beats plus raised guidance made for a very healthy stock on Monday.

1 month ago - The Motley Fool

Shockwave Medical Reports Narrower Than Expected Q2 Loss; Guides Above Consensus

Shockwave Medical Inc's (NASDAQ: SWAV) second-quarter FY21 sales were up 4-fold to $55.9 million beating the Wall Street consensus of $45.17 million. The growth was primarily driven by the launch of the...

1 month ago - Benzinga

Shockwave Medical (SWAV) Reports Q2 Loss, Tops Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 97.56% and 28.12%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

ShockWave Medical: Q2 Earnings Insights

Shares of ShockWave Medical (NASDAQ:SWAV) moved higher by 0.6% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 98.21% year over year to ($0.01),...

1 month ago - Benzinga

Shockwave Medical Reports Second Quarter 2021 Financial Results

SANTA CLARA, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calc...

1 month ago - GlobeNewsWire

Why ShockWave Medical (SWAV) Might Surprise This Earnings Season

ShockWave Medical (SWAV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

1 month ago - Zacks Investment Research

3 Ridiculously Overpriced Stocks That Could Crash in a Market Correction

Now may be the time to sell these stocks before their bubbles pop.

Other symbols:PTONSNAP
1 month ago - The Motley Fool

Shockwave Medical (SWAV) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Shockwave Medical (SWAV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Shockwave Medical to Present at the Canaccord Genuity 41st Annual Growth Conference

SANTA CLARA, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular d...

1 month ago - GlobeNewsWire

Shockwave Medical to Report Second Quarter 2021 Financial Results on August 9, 2021

SANTA CLARA, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calc...

2 months ago - GlobeNewsWire

SVB Leerink Believes ShockWave Is Well-Positioned In Calcified Cardiovascular Market

SVB Leerink has initiated the coverage of ShockWave Medical Inc (NASDAQ: SWAV) with an Outperform rating and a $208 price target, implying an upside of approximately 25%. The analyst Danielle Antalffy n...

2 months ago - Benzinga

Where ShockWave Medical Stands With Analysts

ShockWave Medical (NASDAQ:SWAV) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 0 2 1 Somewhat Bullish 0 1 1 0 Indifferen...

3 months ago - Benzinga

CMS Grants Transitional Pass-Through (TPT) Payment for Shockwave's Coronary IVL

Provides Incremental Reimbursement in Hospital Outpatient Setting Provides Incremental Reimbursement in Hospital Outpatient Setting

3 months ago - GlobeNewsWire

Why Shockwave Medical Stock Jumped Today

The health tech specialist could save lives -- and deliver impressive growth to shareholders along the way.

4 months ago - The Motley Fool

Shockwave Medical Stock Jumps On Q1 Revenue Growth, Analyst Upgrades

Shockwave Medical Inc (NSDQ: SWAV) first-quarter FY21 sales more than double to $31.9 million beating the Wall Street consensus of $29.9 million. The growth was primarily driven by the launch of the cor...

4 months ago - Benzinga

Shockwave Medical (SWAV) Reports Q1 Loss, Tops Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of -61.90% and 1.44%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Recap: ShockWave Medical Q1 Earnings

Shares of ShockWave Medical (NASDAQ:SWAV) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 15.25% year over year to ($0.68), which missed the...

4 months ago - Benzinga

Shockwave Medical Reports First Quarter 2021 Financial Results

SANTA CLARA, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calci...

4 months ago - GlobeNewsWire

Medical Product Stock Q1 Earnings on May 10: MRVI, TGTX & More

The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.

Other symbols:MRVINSTGSDCTGTX
4 months ago - Zacks Investment Research

ShockWave Medical's Earnings Outlook

ShockWave Medical (NASDAQ:SWAV) releases its next round of earnings this Monday, May 10. Get the latest predictions in Benzinga's essential guide to the company's Q1 earnings report.

4 months ago - Benzinga

CMS Proposes Additional Payment for Shockwave's Coronary IVL in Hospital Inpatient Cases

New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2022 Rule New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2022 Rule

4 months ago - GlobeNewsWire